Prisma Health Cancer Institute - Eastside is a clinical research site located in Greenville, South Carolina, United States 29615.
Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
Prisma Health Cancer Institute - Eastside has participated in 246 clinical trials with 168 currently active.
Therapeutic areas: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Sponsors: Children's Oncology Group, National Cancer Institute (NCI), SWOG Cancer Research Network.
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Prisma Health Cancer Institute - Eastside has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Prisma Health Cancer Institute - Eastside has 246 clinical trials on record, with 168 currently active. Their work covers B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Prisma Health Cancer Institute - Eastside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.